EN DE
STOCK COMPARISON

Qingdao Baheal Medical vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how Qingdao Baheal Medical (301015) and McKesson (MCK) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Qingdao Baheal Medical trades at ¥26.43 versus a fair value of ¥19.87 (-25%), while McKesson trades at $881 versus $819 (-7%).
Qingdao Baheal Medical
301015.SHE · CNY · Health Care
-25%
upside to fair value
overvalued
Price¥26.43
Fair Value¥19.87
Quality61/100
McKesson
MCK · USD · Health Care
-7%
upside to fair value
fairly valued
Price$881
Fair Value$819
Quality66/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Qingdao Baheal MedicalMcKesson
Valuation
27.5×P/E (TTM)23.0×
1.87×P/S (TTM)0.27×
5.64×P/BNegative equity
16.5×EV/EBITDA16.1×
n/aPEG1.57×
−24.8%Fair value upside−6.9%
2.2%Dividend yield0.4%
¥0.57Dividend per share$3.17
Profitability
13%Operating margin2%
1.70×EBIT margin trend (5Y)1.60×
22%Return on equityNegative equity
6%Return on assets5%
Growth
-3%Revenue growth (YoY)6%
0.0%Avg. growth/yr (3Y)13.4%
5.0%Avg. growth/yr (5Y)11.1%
+11.5%Value creation/yr+40.2%
Balance & size
7.8×Interest coverage (EBIT/interest)26.1×
0.51×Debt / equityNegative equity
$2BMarket cap$109B
mixedGrowth qualityhealthy

McKesson leads: 4 to 9 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Qingdao Baheal Medicalof which business quality 61 · market factors 62 McKessonof which business quality 65 · market factors 65
ProfitabilityMargins and returns on capital today
56
49
Quality GrowthAre margins and returns improving?
27
65
CashflowEarnings quality: real cash, not paper profit
63
47
Fin. StrengthBalance sheet, leverage, solvency risk
65
72
InvestmentDisciplined investing over empire-building
65
76
Low VolatilityCalm price path (market factor)
69
83
MomentumPrice trend over the last 3–12 months (market factor)
63
56
52W MomentumDistance to the 52-week high (market factor)
52
60
Net IssuanceShare count: buybacks or dilution?
91
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyQingdao Baheal MedicalPrice ¥26.43McKessonPrice $881
DCF Models-16%below the price¥22.19+10%close to the price$969
Earnings-Based-64%below the price¥9.57-50%below the price$444
Dividend Discountn/a-93%below the price$57.26
Multiples-22%below the price¥20.74-4%close to the price$848
Asset-Based-88%below the price¥3.14n/a
Growth DCF-18%below the price¥21.74+7%close to the price$944
Economic Profit-62%below the price¥10.08-44%below the price$497
Growth Earnings-31%below the price¥18.15-20%below the price$708
Minimum-88%below the price¥3.14-93%below the price$57.26
Maximum-16%below the price¥22.19+10%close to the price$969
Median-31%below the price¥18.15-20%below the price$708
Geometric mean-52%below the price¥12.76-44%below the price$492

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Qingdao Baheal Medical: 22 of 24 models see the stock below the current price.

McKesson: 13 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Qingdao Baheal Medical
Price ¥26.43
Fair Value ¥19.87
Bear ¥14.90Bull ¥24.83
McKesson
Price $881
Fair Value $819
Bear $605Bull $1,034

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Qingdao Baheal Medical · Health Care

Quality score61 · above median
Fair value upside-25% · below median

McKesson · Health Care

Quality score66 · Top 25%
Fair value upside-7% · above median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Qingdao Baheal Medical trades at ¥26.43 versus a fair value of ¥19.87 (-25%), while McKesson trades at $881 versus $819 (-7%).

McKesson has the higher quality score (66/100).

Open McKesson live analysis →
Qingdao Baheal Medical · McKesson

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Qingdao Baheal Medical

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to McKesson

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.